Hispanics With Primary Biliary Cirrhosis Are More Likely to Have Features of Autoimmune Hepatitis and Reduced Response to Ursodeoxycholic Acid Than Non-Hispanics

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 8, 2014, Pages 1398-1405

  Levy, Cynthia ^a   Naik, Jahnavi ^a   Giordano, Christin ^a   Mandalia, Amar ^a   O'Brien, Christopher ^a   Bhamidimarri, Kalyan R ^a   Schiff, Eugene R ^a   Martin, Paul ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cholestasis; Ethnic Origin; Health Disparities; Prognosis

Indexed keywords

ALBUMIN; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BILIRUBIN; IMMUNOGLOBULIN G; MERCAPTOPURINE; MITOCHONDRION ANTIBODY; MYCOPHENOLIC ACID; PREDNISONE; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID; CHOLAGOGUE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; BODY MASS; BRAIN DISEASE; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DRUG TREATMENT FAILURE; END STAGE LIVER DISEASE; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FATIGUE; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH INSURANCE; HISPANIC; HUMAN; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRURITUS; SJOEGREN SYNDROME; SOCIAL STATUS; TREATMENT RESPONSE; DEATH; DRUG HYPERSENSITIVITY; ETHNIC DIFFERENCE; HEPATIC ENCEPHALOPATHY; HISTOLOGY; LOW DRUG DOSE; PORTAL HYPERTENSION; STOMACH VARICES BLEEDING; ADOLESCENT; COMPLICATION; ETHNIC GROUP; HEPATITIS, AUTOIMMUNE; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHOLAGOGUES AND CHOLERETICS; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HEPATITIS, AUTOIMMUNE; HISPANIC AMERICANS; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID; YOUNG ADULT;

EID: 84904381548     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.12.010     Document Type: Article

References (19)

1. Kim W.R., Lindor K.D., Locke G.R., et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000, 119:1631-1636.
2. Boonstra K., Beuers U., Ponsioen C.Y. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. JHepatol 2012, 56:1181-1188.
3. Ennis SR, Rios-Vargas M, Albert NG. The Hispanic population: 2010 [updated 2011]. Available at: Accessed September 7,2012. http://www.census.gov/prod/cen2010/briefs/c2010br-04.pdf.
4. Centers for Disease Control and Prevention, CDC. Leading causes of death and numbers of deaths, by sex, race, and Hispanic origin: United States, 1980 and 2006 [updated 2010]. Available at: Accessed September 7,2012. http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_14.pdf.
5. Peters M.G., Di Bisceglie A.M., Kowdley K.V., et al. Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology 2007, 46:769-775.
6. Miami Dade County QuickFacts from the US Census Bureau [updated 2011]. Available at: Accessed December 6,2012. http://quickfacts.census.gov/qfd/states/12/12086.html.
7. US Census Bureau: about race [updated 2010]. Available at: Accessed December 17,2012. http://www.census.gov/population/race/about/.
8. Chazouilleres O., Wendum D., Serfaty L., et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998, 28:296-301.
9. Kuiper E.M., Zondervan P.E., van Buuren H.R. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol 2010, 8:530-534.
10. Hennes E.M., Zeniya M., Czaja A.J., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176.
11. Neuhauser M., Bjornsson E., Treeprasertsuk S., et al. Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol 2010, 105:345-353.
12. Momah N., Silveira M.G., Jorgensen R., et al. Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis. Liver Int 2012, 32:790-795.
13. Boberg K.M., Chapman R.W., Hirschfield G.M., et al. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. JHepatol 2011, 54:374-385.
14. Chung G.E., Kim D., Kim W., et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. JHepatol 2012, 57:150-156.
15. Pagadala M.R., Zein C.O., Dasarathy S., et al. Prevalence of hypothyroidism in nonalcoholic fatty liver disease. Dig Dis Sci 2012, 57:528-534.
16. Rodriguez-Torres M., Rios-Bedoya C.F., Ortiz-Lasanta G., et al. Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis. Ann Hepatol 2008, 7:72-77.
17. Hindi M., Levy C., Couto C.A., et al. Primary biliary cirrhosis is more severe in overweight patients. JClin Gastroenterol 2013, 47:e28-e32.
18. Zein C.O., Beatty K., Post A.B., et al. Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment. Hepatology 2006, 44:1564-1571.
19. Carbone M., Mells G.F., Pells G., et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology 2013, 144:560-569.e7. quiz e13-e14.